The Study of Infrared Imaging on Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2005 by National Taiwan University Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

National Taiwan University Hospital

ClinicalTrials.gov Identifier:

NCT00166998

First received: September 12, 2005

Last updated: NA

Last verified: February 2005

History: No changes posted

Purpose

Breast cancer can cause focal temperature increase on the breast skin due to vasodilatation mediated by NO secretion from cancer cells. Our study is to evaluate this situation and to assess the diagnostic efficacy of infrared imaging (thermography)on breast cancer.

Condition
Breast Neoplasms

Study Type:	Observational
Study Design:	Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective

Resource links provided by NLM:

Genetics Home Reference related topics: breast cancer

MedlinePlus related topics: Breast Cancer Cancer

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment:	600
Study Start Date:	March 2005
Estimated Study Completion Date:	July 2006

Detailed Description:

Malignant breast neoplasms can secrete NO to induce focal vasodilatation and increased blood flow and angiogenesis to the tumor, thus increase the focal temperature, which can be evaluated by breast thermography (infrared imaging). We will evaluate the efficacy of infrared imaging for detection and diagnosis of breast cancer, and if infrared imaging can effectively differentiate malignant from benign breast dieases and the sensitivity, specificity, false-negative rate will also be estimated.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

normal group: women who has normal mammograms or ultrasound in 6 months abnormal group: women who has suspicious findings on mammograms or ultrasound in recent 6 months

Exclusion Criteria:

women who don't fit the above inclusion criteria

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00166998

Contacts

Contact: Jane Wang, MD

886-2-23123456 ext 5565

hstjen@yahoo.com.tw

Locations

Taiwan
National Taiwan University Hospital	Recruiting
Taipei, Taiwan, 100
Contact: Jane Wang, MD 886-2-23123456 ext 5565 hstjen@yahoo.com.tw
Principal Investigator: Jane Wang, MD
Sub-Investigator: Yuh-Show Tsai, PhD

Sponsors and Collaborators

National Taiwan University Hospital

Investigators

Principal Investigator:

Jane Wang, MD

National Taiwan University Hospital

More Information

Publications:

Parisky YR, Sardi A, Hamm R, Hughes K, Esserman L, Rust S, Callahan K. Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions. AJR Am J Roentgenol. 2003 Jan;180(1):263-9.

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Wang J, Chang KJ, Chen CY, Chien KL, Tsai YS, Wu YM, Teng YC, Shih TT. Evaluation of the diagnostic performance of infrared imaging of the breast: a preliminary study. Biomed Eng Online. 2010 Jan 7;9:3.

ClinicalTrials.gov Identifier:	NCT00166998 History of Changes
Other Study ID Numbers:	9361701271
Study First Received:	September 12, 2005
Last Updated:	September 12, 2005
Health Authority:	Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:

Breast neoplasms
diagnosis

Additional relevant MeSH terms:

Breast Neoplasms
Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 16, 2013

To Top